Phase II study of pirarubicin (THP) in patients with cervical, endometrial and ovarian cancer: Study of the clinical screening group of the European Organization for Research and Treatment of Cancer (EORTC)
- 31 December 1993
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 29 (3), 350-354
- https://doi.org/10.1016/0959-8049(93)90384-r
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Chemotherapy of Endometrial AdenocarcinomasPublished by S. Karger AG ,2015
- Pirarubicin in advanced breast cancer: A French Cooperative phase II studyEuropean Journal of Cancer and Clinical Oncology, 1990
- Pharmacokinetics and metabolism of pirarubicin in advanced cancer patientsEuropean Journal of Cancer and Clinical Oncology, 1988
- A randomized study of cyclophosphamide and cis-platinum with or without doxorubicin in advanced ovarian carcinomaGynecologic Oncology, 1987
- Treatment of advanced ovarian cancer: A randomised trial comparing adriamycin or 4′epi-adriamycin in combination with cisplatin and cyclophosphamideMedical and Pediatric Oncology, 1986
- Relationship between the intracellular level and growth inhibition of a new anthracycline 4′O-tetrahydropyranyl-adriamycin in friend leukemia cell variantsLeukemia Research, 1985
- Phase I clinical trial of a new anthracycline: 4′-o-tetrahydropyranyl adriamycinInvestigational New Drugs, 1983
- Rapid uptake by cultured tumor cells and intracellular behavior of 4'-O-tetrahydropyranyladriamycin.The Journal of Antibiotics, 1983
- Low heart and skin toxicity of a tetrahydropyranyl derivative of adriamycin (THP-ADM) as observed by electron and light microscopy.The Journal of Antibiotics, 1979
- Tetrahydropyranyl derivatives of daunomycin and adriamycin.The Journal of Antibiotics, 1979